BGM Group Ltd. Class A Ordinary Shares (BGM) Stock Price

BGMStock

$0.27−96.67%52W

Market Cap$106.17M

P/E—

PEG Ratio—

Div yield—

Beta1.85

BGM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-87.40%

Price vs S&P 500 (4W)-15.19%

VGM Score39.09

P/CF (Annual)232.17x

Book Value / Share (Quarterly)$1.95

P/TBV (Annual)4.31x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-16.38%

Cash Flow / Share (Quarterly)$-0.02

Price vs S&P 500 (YTD)-105.17%

Gross Margin (TTM)16.64%

Net Profit Margin (TTM)-52.59%

EPS (TTM)$-0.13

10-Day Avg Trading Volume0.49M

EPS Excl Extra (TTM)$-0.13

Revenue Growth (5Y)-5.39%

EPS (Annual)$-0.18

ROI (Annual)-5.08%

Gross Margin (Annual)16.64%

Net Profit Margin (5Y Avg)-13.58%

Cash / Share (Quarterly)$0.05

Revenue Growth QoQ (YoY)88.33%

ROA (Last FY)-4.60%

Revenue Growth TTM (YoY)51.09%

EBITD / Share (TTM)$-0.10

ROE (5Y Avg)-3.78%

Operating Margin (TTM)-33.18%

Cash Flow / Share (Annual)$-0.02

P/B Ratio0.32x

P/B Ratio (Quarterly)4.26x

Net Income / Employee (Annual)$-61,700

Net Interest Coverage (TTM)-1.48x

ROA (TTM)-6.22%

EPS Incl Extra (Annual)$-0.18

Current Ratio (Annual)1.24x

Quick Ratio (Quarterly)0.67x

3-Month Avg Trading Volume0.37M

52-Week Price Return-96.67%

Revenue / Employee (TTM)$117,400

Tangible BV / Share (Quarterly)$1.93

P/S Ratio (Annual)3.31x

Asset Turnover (Annual)0.09x

52-Week High$11.80

Operating Margin (5Y Avg)-6.72%

EPS Excl Extra (Annual)$-0.18

CapEx CAGR (5Y)29.70%

26-Week Price Return-76.15%

Quick Ratio (Annual)0.67x

13-Week Price Return-14.54%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.24x

Enterprise Value$117.36M

Revenue / Share Growth (5Y)-25.20%

Asset Turnover (TTM)0.12x

Revenue / Employee (Annual)$117,400

Inventory Turnover (Annual)2.51x

Pretax Margin (Annual)-52.58%

Cash / Share (Annual)$0.05

3-Month Return Std Dev124.34%

Gross Margin (5Y Avg)11.26%

Net Income / Employee (TTM)$-61,700

EBITDA CAGR (5Y)-38.03%

ROE (Last FY)-5.10%

Net Interest Coverage (Annual)-1.48x

EPS Basic Excl Extra (Annual)$-0.18

P/FCF (TTM)774.23x

Receivables Turnover (TTM)13.08x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.13

Receivables Turnover (Annual)13.08x

ROI (TTM)-6.92%

P/S Ratio (TTM)3.31x

Pretax Margin (5Y Avg)-13.96%

Revenue / Share (Annual)$0.33

Tangible BV / Share (Annual)$1.93

Price vs S&P 500 (52W)-114.98%

Year-to-Date Return-93.21%

5-Day Price Return-13.09%

EPS Normalized (Annual)$-0.18

ROA (5Y Avg)-3.33%

Net Profit Margin (Annual)-52.59%

Month-to-Date Return-11.21%

EBITD / Share (Annual)$-0.10

Operating Margin (Annual)-33.18%

ROI (5Y Avg)-3.89%

EPS Basic Excl Extra (TTM)$-0.13

P/TBV (Quarterly)4.31x

P/B Ratio (Annual)4.26x

Inventory Turnover (TTM)2.51x

Pretax Margin (TTM)-52.58%

Book Value / Share (Annual)$1.95

Price vs S&P 500 (13W)-17.33%

Beta1.85x

P/FCF (Annual)13.37x

Revenue / Share (TTM)$0.19

ROE (TTM)-6.96%

52-Week Low$0.23

vGradeC

gGradeC

mGradeF

vgmGradeD

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
BGMBGM Group Ltd. Class A Ordinary Shares	C	C	F	$0.27
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About BGM Group Ltd. Class A Ordinary Shares

BGM Group Ltd manufactures pharmaceutical active ingredients and medical products through biopharmaceutical and bio-extraction operations. Its core revenue comes from oxytetracycline APIs, licorice preparations, and traditional Chinese medicine derivatives (TCMD), with secondary contributions from crude heparin sodium and specialty sausage casings. The company specializes in producing essential pharmaceutical intermediates for the healthcare industry.